Table 1.
Descriptive characteristics of clinimetric scales.
| Scale | Value | Theoretical range |
|---|---|---|
| HY (median, IQR) | 3 (2.5–4) | 1–5 |
| Stages 1/1.5 | 11.4% | |
| Stages 2/2.5 | 25.9% | |
| Stage 3 | 34.4% | |
| Stage 4 | 21.8% | |
| Stage 5 | 6.5% | |
| SE-ADL (median, IQR) | 75 (60–80) | 0–100 |
| MMSE score (mean, SD) | 26.2 (4.0) | 0–30 |
| BDI score (mean, SD) | 15.43 (8.58) | 0–63 |
| PDQ-39 SI score (mean, SD) | 31.4 (15.3) | 0–100 |
| MDS-UPDRS subscores: | ||
| Total | 76.76 (30.71) | 0–260 |
| Part I (mean, SD) | 12.5 (6.79) | 0–52 |
HY, Hoehn and Yahr stage; IQR, interquartile range; SE-ADL, Schwab and England Activities of Daily Living Scale; MMSE, Minimental State Examination; BDI, Beck Depression Inventory; PDQ-39 SI, Parkinson's Disease Questionnaire Summary Index; MDS-UPDRS, Movement Disorders Society's Unified Parkinson's Disease Rating Scale.